Dr. Mike Mullan’s Alzheimer Research Has Helped in Finding Possible Cures and Treatments for the Disease
Alzheimer’s disease is basically a form of neurodegenerative disorder, which attacks neurons in brain and impacts an individual’s memory, thought, language and reasoning. This disease slowly affects the behavior of an individual, his personality, memory and the ability to perform routine activities. It has been indicated through studies that there about millions of people around the world, who suffer from Alzheimer’s disease.
As per the researchers, the molecule CD4oL is elevated in the patients suffering from Alzheimer’s disease. According to the Alzheimer’s Association, it has been estimated that in every 71 seconds, an individual in the US develops the disease and by mid-century there is a possibility of people developing Alzheimer’s in every 33 seconds.
Currently, there are about 5.2 million people from different age groups, in America, suffering from the disease and it has been assumed that by 2050, the number of patients will increase to a range of approximately over 11 million to 16 million.
Dr. Mike Mullan, the Director of Roskamp Institute, is a reputed professional in the biomedical field. The Roskamp Institute specializes in the research and studies on neuropsychiatric and neurodegenerative disorders and addictions.
Dr. Mullan has performed thorough studies on several neurodegenerative disorders with an emphasis in finding the causes and cures for Alzheimer’s disease. Dr. Mullan’s Alzheimer research sheds light on a large number of surprising facts. According to him, one of the main causes of the disease is the abnormal or excess accumulation of beta-amyloid, a type of protein in the brain.
Dr. Mullan’s Alzheimer study has played a vital role on the development of several possible cures and treatments that have been tested to help in slowing down the accumulation of beta-amyloid and related inflammation.
About Dr. Mike Mullan Dr Mike Mullan has been working in the biomedical field for many years. He is a leading researcher with special expertise in assessment of the earliest cognitive symptoms and stages of Alzheimer’s disease. Mullan’s Alzheimer research works are also published in various articles which help students and researchers for making new discoveries.
Find out more about his Alzheimer research works, by browsing through www.rfdn.org or www.mullanalzheimer.com or www.mullanalzheimer.info.